News

BioSense Webster eMARQable Clinical Study nMARQ System Atrial Fibrillation

Biosense Webster Inc. announced the first patient has been enrolled in the reMARQable clinical study. ReMARQable will assess the safety and efficacy of the use of the nMARQ Pulmonary Vein...

CardioFocus Inc. announced that as of late 2012, more than 1,000 clinical cases have been performed worldwide using the HeartLight technology. The company hosted an expert symposium to review the...

Endosense TactiCath

Endosense has announced that the results of its EFFICAS I prospective multi-center study have led to the development of guidelines for target and minimum contact force (CF), as well as minimum...

Top stories of 2012 in cardiology

To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are the top 25 stories from 2012, and the...

Boston Scientific Blazer Open-Irrgated Catheter Atrial Fibrillation ZERO AF

The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer open-irrigated temperature ablation Catheter...

EPi-Sense Guilded Coagulation Device nContact VisiTrax

nContact Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing...

October 19, 2012 — Boston Scientific Corp. entered into a definitive agreement to acquire privately-held Rhythmia Medical Inc., a developer of next-generation...

October 12, 2012 — Estech, a provider of minimally invasive cardiac ablation devices, last month announced the market release of its Cobra Fusion...

September 19, 2012 — This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to begin performing surgeries in the Dual Epicardial...

September 11, 2012 — St. Jude Medical Inc. announced the realignment of its product divisions into two new operating units: the Implantable Electronic Systems Division (IESD) and the...

September 11, 2012 — Since the previous consensus document was published in 2007, catheter and surgical ablation of atrial...

August 20, 2012 — The Baylor Heart Hospital in Plano, Texas, recently became the first hospital in the world to merge two highly advanced technologies for...

Biosense Webster Inc. launched the new Carto 3 MEM (Multi-Electrode Mapping) Version in the United States. It is the latest advancement on the Carto 3 system platform.

July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and target its ablation to greatly reduce procedure time and substantially improve...

 

June 18, 2012 — Epicardial ablation device maker Contact Inc. announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary...

June 18, 2012 — Endosense announced its TactiCath Quartz force-sensing ablation catheter has been CE mark approved...

June 15, 2012 —Endosense, a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias, has...

June 15, 2012 — Cardiosolutions Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Dexterity Steerable Introducer, a next-generation...

The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in...

May 24, 2012 —Advanced Cardiac Therapeutics Inc., a developer of temperature-sensing cardiac ablation systems, today announced results of several studies related to the company’s Tempasure cardiac...